European Journal of Cancer
Volume 39, Issue 17 , Pages 2462-2469 , November 2003

Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy

Received 3 April 2003 ,Revised 22 May 2003 ,Accepted 3 July 2003.

References 

  1. van Dongen J, Voogd AC, Fentiman IA, et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy (European Organization for Research and Treatment of Cancer 10801 Trial). J. Natl. Cancer Inst. 2000;92:1143–1150
  2. Fisher B, Anderson S, Bryant J, et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 2002;347:1233–1241
  3. Blichert-Toft M, Rose C, Andersen JA, et al.  Danish Randomized trial comparing breast conservation therapy with mastectomy (six years of life-table analysis). J. Natl. Cancer Inst. Monogr. 1992;11:19–25
  4. Noguchi M, Saito Y, Mizukami Y, et al.  Breast deformity, its correction, and assessment of breast conserving surgery. Breast Cancer Res. Treat. 1992;18:111–118
  5. Clough KB, Nos C, Salmon RJ, Soussaline M, Durand JC. Conservative treatment of breast cancers by mammaplasty and irradiation (a new approach to lower quadrant tumours). Plast. Reconstr. Surg. 1994;96:363–370
  6. Clough KB, Kroll SS, Audretsch W. An approach to the repair of partial mastectomy defects. Plast. Reconstr. Surg. 1999;104:409–420
  7. Raja MAK, Straker VF, Rainsbury RM. Extending the role of breast-conservation therapy by immediate volume replacement. Br. J. Surg. 1997;84:101–105
  8. Shrotria S. Techniques for improving the cosmetic outcome of breast conserving surgery. Eur. J. Surg. Oncol. 2001;27:109–112
  9. Masetti R, Pirulli PG, Magno S, Franceschini G, Chiesa F, Antinori A. Oncoplastic techniques in the conservative surgical treatment of breast cancer. Breast Cancer. 2000;7:276–280
  10. Petit JY, Rietjens M, Garusi C. Breast reconstructive techniques in cancer patients (which one, when to apply, which immediate and long term risks?). Crit. Rev. Oncol. Hematol. 2001;38:231–239
  11. Dixon JM, Venizelos B, Chan P. Latissimus dorsi mini-flap (a technique for extending breast conservation). Breast. 2002;11:58–65
  12. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic Findings from the National Surgical Adjuvant Breast Project (Procotol 6). Cancer. 1986;57:1717–1724
  13. Veronesi U, Marubini E, Del Vecchio M, et al.  Local recurrences and distant metastases after conservative breast cancer treatments (partly independent events). J. Natl. Cancer Inst. 1995;87:19–27
  14. Haffty BG, Carter D, Flynn SD, et al.  Local recurrence versus new primary (clinical analysis of 82 breast relapses and potential applications of genetic fingerprinting). Int. J. Radiat. Oncol. Biol. Phys. 1993;27:575–583
  15. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histological multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast conserving surgery. Cancer. 1985;56:979–990
  16. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer (whole-organ analysis and clinical implications). Br. J. Cancer. 1996;74:820–824
  17. Macmillan RD, Purusotham AD, Mallon E, Love JG, George WD. Tumour bed positivity predicts outcome after breast-conservation therapy. Br. J. Surg. 1998;85:1559–1562
  18. Ohtake T, Abe R, Kimijima I, et al.  Intraductal extension of primary invasive breast carcinoma treated by breast-conservation therapy. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer. 1995;76:32–45
  19. Sarrazin D, Le M, Rouesse J, et al.  Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer. 1984;53:1209–1213
  20. Veronesi U, Saccozzi R, del Vecchio M, et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N. Engl. J. Med. 1981;305:6–11
  21. Fisher B, Bauer M, Margolese R, et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N. Engl. J. Med. 1985;312:665–673
  22. Fisher B, Redmond C, Poisson R, et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1989;320:822–828
  23. Fisher B, Anderson S, Redmond CK, et al.  Reanalysis and Results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995;333:1456–1461
  24. van Dongen JA, Bartelink H, Fentiman IS, et al.  Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer (EORTC trial 10801, breast conservation compared with mastectomy in TNM Stage I and II breast cancer). Eur. J. Cancer. 1992;28A:801–805
  25. Lichter AS, Lippman ME, Danforth DN, et al.  Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J. Clin. Oncol. 1992;10:976–983
  26. Straus K, Lichter A, Lippman M, et al.  Results of the National Cancer Institute Early Breast Cancer Trial. J. Natl. Cancer Inst. Monogr. 1992;11:27–32
  27. Jacobson JA, Danforth DN, Cowan KH, et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of Stage I and II breast cancer. N. Engl. J. Med. 1995;332:907–911
  28. Veronesi U, Luini A, Del Vecchio M, et al.  Radiotherapy after breast-conservation therapy in women with localized cancer of the breast. N. Engl. J. Med. 1993;328:1587–1591
  29. Veronesi U, Marubini E, Mariani L, et al.  Radiotherapy after breast-conservation therapy in small breast carcinoma: Long-term results of a randomized trial. Ann. Oncol. 2001;12:997–1003
  30. Clark RM, McCulloch PB, Levine MN, et al.  Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J. Natl. Cancer Inst. 1992;84:683–689
  31. Whelan T, Clark R, Roberts R, Levine M, Foster G. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality (results from a randomized trial). Int. J. Radiat. Oncol. Biol. Phys. 1994;30:11–16
  32. Clark RM, Whelan T, Levine M, et al.  Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer (an update. Ontario Clinical Oncology Group). J. Natl. Cancer Inst. 1996;88:1659–1664
  33. Forrest AP, Stewart HJ, Everington D, et al.  Randomised controlled trial of conservation therapy for breast cancer (6-year analysis of the Scottish trial). Lancet. 1996;348:708–713
  34. Bartelink H, Horiot J-C, Poortmans P, et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 2001;345:1378–1387
  35. Mariani L, Salvadori B, Marubini E, et al.  Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur. J. Cancer. 1998;34:1156–1162
  36. Blichert-Toft M, Brincker H, Andersen A, et al.  A Danish randomized trial comparing breast-conserving therapy with mastectomy in mammary carcinoma. Acta Oncol. 1988;27:671–677
  37. Voogd AC, Nielsen M, Peterse JL, et al.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and stage II breast cancer (pooled results of two large European randomized trials). J. Clin. Oncol. 2001;19:1688–1697
  38. Fredriksson I, Liljegren G, Arnesson L-G, et al.  Time trends in the results of breast conservation in 4694 women. Eur. J. Cancer. 2001;37:1537–1544
  39. Bartelink H, Borger JH, van Dongen JA, Peterse JL. The impact of tumor size and histology on local control after breast-conserving therapy. Radiother. Oncol. 1988;11:297–303
  40. Dalberg K, Mattsson A, Rutqvist LE, Johansson U, Riddez L, Sandelin K. Breast conserving surgery for invasive breast cancer (risk factors for ipsilateral breast tumor recurrences). Breast Cancer Res. Treat. 1997;43:73–86
  41. Fowble BL, Solin LJ, Schultz DJ, Goodman RL. Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:269–277
  42. Kurtz JM, Jacquemier J, Amalric R, et al.  Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 1990;65:1867–1878
  43. Fourquet A, Campana F, Zafrani B, et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer (a 25-year follow-up). Int. J. Radiat. Oncol. Biol. Phys. 1989;17:719–725
  44. Elkhuizen PHM, Voogd AC, van den Broek LCJM, et al.  Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas (a case-control study of histological factors and alterations in oncogene expression). Int. J. Radiat. Oncol. Biol. Phys. 1999;45:73–83
  45. Voogd AC, Peterse JL, Crommelin MA, et al.  Histological determinants for different types of local recurrence after breast-conserving therapy for invasive breast cancer. Eur. J. Cancer. 1999;35:1828–1837
  46. Newman LA, Buzdar AU, Singletary SE, et al.  A prospective trial of preoperative chemotherapy in respectable breast cancer (predictors of breast-conservation therapy feasibility). Ann. Surg. Oncol. 2002;9:228–234
  47. Merajver SD, Weber BL, Cody R, et al.  Breast conservation and prolonged chemotherapy for locally advanced breast cancer (the University of Michigan experience). J. Clin. Oncol. 1997;15:2873–2881
  48. Veronesi U, Bonadonna G, Zurrida S, et al.  Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann. Surg. 1995;222:612–618
  49. van der Hage JA, van de Velde CJH, Julien J-P, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preooperative chemotherapy in primary operable breast cancer (results from the European Organization for Research and Treatment of Cancer Trial 10902). J. Clin. Oncol. 2001;19:4224–4237
  50. Touboul E, Buffat L, Lefranc J-P, et al.  Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996;34:1019–1028
  51. Fisher B, Bryant J, Wolmark N, et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol. 1998;16:2672–2685
  52. Rouzier R, Extra J-M, Carton M, et al.  Primary chemotherapy for operable breast cancer (incidence and prognostic significance of ipsilateral breast tumour recurrence after breast-conservation therapy). J. Clin. Oncol. 2001;19:3828–3835

PII: S0959-8049(03)00605-1

doi: 10.1016/S0959-8049(03)00605-1

European Journal of Cancer
Volume 39, Issue 17 , Pages 2462-2469 , November 2003

Article Tools